IntrinsiQ Acquires Pharma Specialist WWMR

In the US, medical information firm IntrinsiQ has acquired pharma and biotech market research and consulting specialist WWMR. Terms were not disclosed.

WWMR was founded in 1994 to provide qual and quant market research, product and market assessments, forecasts, and economic analysis conducted through every stage of the clinical research and drug development process. The firm specializes in oncology research.

Through the acquisition, IntrinsiQ is now able to offer a complete suite of primary and secondary oncology market research capabilities, to provide insight into how oncologists perceive treatment standards and how they practise medicine. It will also enable the firms to assemble primary research panels linked to IntrinsiQ's database of more than 600 oncologists.

'This alignment is a perfect marriage because of our organizations' shared mission of improving the quality and understanding of cancer care,' said Susan Olsen, WWMR founder and President, who becomes VP of Consulting Services in IntrinsiQ's pharma information division. 'IntrinsiQ has long been the gold standard in oncology data, and we're thrilled to join their team.'

WWMR will retain its name and maintain offices in San Mateo, California, and all its employees will join IntrinsiQ. The firm will continue to offer its custom consulting and market research services in non-oncology markets.

Web sites: www.intrinsiq.com and www.wwmr.com .